Nanobiotix S.A.
NBTXNASDAQHealthcare● Active
$36.47
+$1.01(+2.85%)
Market Cap$1.8B
P/E Ratio—
52W High$57.14
52W Low$4.18
Nanobiotix S.A. (NBTX) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
NBTX · earnings · updated Jun 8, 2026
Latest Earnings
Q1 FY2026Report Date: Mar 31, 2026EPS Actual
-$0.46
Est. $0.30 · -250.7%
Revenue
$0.00B
Est. $0.05B · -93.2%
Fiscal Period
Q1 FY2026
FY ends December
Report Date
Mar 31, 2026
After Market Close
▼ Miss EPS▼ Miss Revenue
NBTX reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Sep 30, 2026 | -$0.32 | — | — | — | $0.02B | — |
| ▼ Q1 FY2026 | Mar 31, 2026 | $0.30 | -$0.46 | -250.7% | $0.00B | $0.05B | -93.2% |
| ▲ Q3 FY2025 | Sep 30, 2025 | -$0.25 | -$0.13 | +45.9% | $0.03B | $0.02B | +31.2% |
| ▼ Q2 FY2025 | Apr 2, 2025 | -$0.62 | -$1.01 | -63.5% | $-0.02B | $0.00B | -709.2% |
| ▲ Q4 FY2024 | Nov 12, 2024 | -$0.51 | -$0.50 | +2.5% | $0.01B | $0.01B | -3.5% |
| ▲ Q2 FY2024 | Apr 24, 2024 | -$0.83 | -$0.33 | +60.4% | $0.04B | — | — |
| ▼ Q4 FY2023 | Nov 13, 2023 | -$0.59 | -$0.87 | -47.6% | $0.00B | $0.00B | -9.1% |
| — Q1 FY2023 | Mar 28, 2023 | — | -$0.95 | — | $0.00B | — | — |
Q3 FY2026
Sep 30, 2026
EPS Actual
—
EPS Est.
-$0.32
EPS Surpr.
—
Revenue
—
Q1 FY2026
Mar 31, 2026Miss
EPS Actual
-$0.46
EPS Est.
$0.30
EPS Surpr.
-250.7%
Revenue
$0.00B
Q3 FY2025
Sep 30, 2025Beat
EPS Actual
-$0.13
EPS Est.
-$0.25
EPS Surpr.
+45.9%
Revenue
$0.03B
Q2 FY2025
Apr 2, 2025Miss
EPS Actual
-$1.01
EPS Est.
-$0.62
EPS Surpr.
-63.5%
Revenue
$-0.02B
Q4 FY2024
Nov 12, 2024Beat
EPS Actual
-$0.50
EPS Est.
-$0.51
EPS Surpr.
+2.5%
Revenue
$0.01B
Q2 FY2024
Apr 24, 2024Beat
EPS Actual
-$0.33
EPS Est.
-$0.83
EPS Surpr.
+60.4%
Revenue
$0.04B
Q4 FY2023
Nov 13, 2023Miss
EPS Actual
-$0.87
EPS Est.
-$0.59
EPS Surpr.
-47.6%
Revenue
$0.00B
Q1 FY2023
Mar 28, 2023
EPS Actual
-$0.95
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2025 | $0.01 | $0.01 | $0.01 | 1 |
| Q3 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
| Q2 FY2025 | $-0.30 | $-0.30 | $-0.30 | 1 |
| Q2 FY2024 | $-0.23 | $-0.23 | $-0.23 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2024 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q1 FY2026 | Mar 31, 2026 | -250.7% | $30.58 | $30.87 | +0.95% |
| ▲ Q3 FY2025 | Sep 30, 2025 | +45.9% | $18.02 | $18.89 | +4.83% |
| ▼ Q2 FY2025 | Apr 2, 2025 | -63.5% | $3.58 | $3.40 | -5.03% |
| ▲ Q4 FY2024 | Nov 12, 2024 | +2.5% | $4.05 | $4.03 | -0.49% |
| ▲ Q2 FY2024 | Apr 24, 2024 | +60.4% | $5.71 | $5.90 | +3.33% |
| ▼ Q4 FY2023 | Nov 13, 2023 | -47.6% | $5.85 | $5.78 | -1.20% |
| — Q1 FY2023 | Mar 28, 2023 | — | $3.45 | $3.60 | +4.35% |
| — Q4 FY2022 | Nov 9, 2022 | — | $3.80 | $3.80 | +0.00% |
Q1 FY2026+0.95%
Report Date
Mar 31, 2026
EPS Beat/Miss
-250.7%
Price Before
$30.58
Price After
$30.87
Q3 FY2025+4.83%
Report Date
Sep 30, 2025
EPS Beat/Miss
+45.9%
Price Before
$18.02
Price After
$18.89
Q2 FY2025-5.03%
Report Date
Apr 2, 2025
EPS Beat/Miss
-63.5%
Price Before
$3.58
Price After
$3.40
Q4 FY2024-0.49%
Report Date
Nov 12, 2024
EPS Beat/Miss
+2.5%
Price Before
$4.05
Price After
$4.03
Q2 FY2024+3.33%
Report Date
Apr 24, 2024
EPS Beat/Miss
+60.4%
Price Before
$5.71
Price After
$5.90
Q4 FY2023-1.20%
Report Date
Nov 13, 2023
EPS Beat/Miss
-47.6%
Price Before
$5.85
Price After
$5.78
Q1 FY2023+4.35%
Report Date
Mar 28, 2023
EPS Beat/Miss
—
Price Before
$3.45
Price After
$3.60
Q4 FY2022+0.00%
Report Date
Nov 9, 2022
EPS Beat/Miss
—
Price Before
$3.80
Price After
$3.80
Avg Beat Reaction+2.56%
Avg Miss Reaction-1.76%
Beat Rate3 / 8 quarters
Largest Move-5.03% (Q2 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: NBTX ends December
Nanobiotix S.A. (NBTX) most recently reported earnings on March 31, 2026 for Q1 FY2026, posting EPS of $-0.46 — missing the analyst consensus of $0.30 by -250.7%. The next NBTX earnings date is expected around September 1, 2026.
Each quarter, investors track NBTX earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. NBTX revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
NBTX's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
NBTX earnings · 5 questionsNanobiotix S.A.'s next earnings report is expected around September 1, 2026. NBTX typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; NBTX historically reports after market close (AMC).
NBTX earnings datewhen is NBTX earningsNBTX next earnings datewhen does NBTX report earningsNBTX earnings calendar
▸ Source: FMP · Nanobiotix S.A. SEC filings · US GAAP · Nanobiotix S.A. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026